Schizandrin A ameliorates cognitive functions via modulating microglial polarisation in Alzheimer’s disease mice

References

• Aryanpour R, Pasbakhsh P, Zibara K, Namjoo Z, Beigi Boroujeni F, Shahbeigi S, Kashani IR, Beyer C, Zendehdel A. 2017. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int Immunopharmacol. 51:131–139.
   PubMed Web of Science ®Google Scholar
• Aslanyan G, Amroyan E, Gabrielyan E, Nylander M, Wikman G, Panossian A. 2010. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine. 17(7):494–499.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu F, Zheng N, Guo M, Bao L, Zhan Y, Zhang M, Zhao Y, Guo W, Ding G. 2019. Wuzhi capsule (Schisandra sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomed Pharmacother. 110:285–293.
   PubMed Web of Science ®Google Scholar
• Condello C, Yuan P, Grutzendler J. 2018. Microglia-mediated neuroprotection, TREM2, and Alzheimer's disease: evidence from optical imaging. Biol Psychiatry. 83(4):377–387.
   PubMed Web of Science ®Google Scholar
• Hansen DV, Hanson JE, Sheng M. 2018. Microglia in Alzheimer's disease. J Cell Biol. 217(2):459–472.
   PubMed Web of Science ®Google Scholar
• Hu XL, Guo C, Hou JQ, Feng JH, Zhang XQ, Xiong F, Ye WC, Wang H. 2019. Stereoisomers of Schisandrin B are potent ATP competitive GSK-3β inhibitors with neuroprotective effects against Alzheimer's disease: stereochemistry and biological activity. ACS Chem Neurosci. 10(2):996–1007.
   PubMed Web of Science ®Google Scholar
• Huang X, Duan X, Wang K, Wu J, Zhang X. 2019. Shengmai injection as an adjunctive therapy for the treatment of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Complement Ther Med. 43:140–147.
   PubMed Web of Science ®Google Scholar
• Jin J, Guo J, Cai H, Zhao C, Wang H, Liu Z, Ge ZM. 2020. M2-like microglia polarization attenuates neuropathic pain associated with Alzheimer's disease. J Alzheimers Dis. 76(4):1255–1265.
   PubMed Web of Science ®Google Scholar
• Katsumoto A, Takeuchi H, Takahashi K, Tanaka F. 2018. Microglia in Alzheimer's disease: risk factors and inflammation. Front Neurol. 9:978.
   PubMed Web of Science ®Google Scholar
• Kong D, Zhang D, Chu X, Wang J. 2018. Schizandrin A enhances chemosensitivity of colon carcinoma cells to 5-fluorouracil through up-regulation of miR-195. Biomed Pharmacother. 99:176–183.
   PubMed Web of Science ®Google Scholar
• Kormosh N, Laktionov K, Antoshechkina M. 2006. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 20(5):424–425.
   PubMed Web of Science ®Google Scholar
• Lane CA, Hardy J, Schott JM. 2018. Alzheimer's disease. Eur J Neurol. 25(1):59–70.
   PubMed Web of Science ®Google Scholar
• Lee K, Ahn J, Lee K, Jang D, Choi J. 2018. Deoxyschizandrin, isolated from Schisandra berries, induces cell cycle arrest in ovarian cancer cells and inhibits the protumoural activation of tumour-associated macrophages. Nutrients. 10(1):91.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang Q, Guan H, Zhou Y, Liu L. 2021. Schisandrin inhibits NLRP1 inflammasome-mediated neuronal pyroptosis in mouse models of Alzheimer's disease. Neuropsychiatr Dis Treat. 17:261–268.
   PubMed Web of Science ®Google Scholar
• Liu N, Zheng JX, Zhuang YS, Zhou ZK, Zhao JH, Yang L. 2017. Anti-inflammatory effects of schisandrin B on LPS-stimulated BV2 microglia via activating PPAR-γ. Inflammation. 40(3):1006–1011.
   PubMed Web of Science ®Google Scholar
• Lyles JT, Tyler P, Bradbury EJ, Nelson K, Brown CF, Pierce ST, Quave CL. 2017. Comparative phytochemical analysis of Chinese and Bay starvine (Schisandra spp.): potential for development as a new dietary supplement ingredient. J Diet Suppl. 14(6):640–652.
   PubMedGoogle Scholar
• Narimanian M, Badalyan M, Panosyan V, Gabrielyan E, Panossian A, Wikman G, Wagner H. 2005. Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. Phytomedicine. 12(10):723–729.
   PubMed Web of Science ®Google Scholar
• Park SY, Park SJ, Park TG, Rajasekar S, Lee SJ, Choi YW. 2013. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. Int Immunopharmacol. 17(2):415–426.
   PubMed Web of Science ®Google Scholar
• Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH. 2010. Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci. 30(45):14946–14954.
   PubMed Web of Science ®Google Scholar
• Qi Y, Cheng X, Gong G, Yan T, Du Y, Wu B, Bi K, Jia Y. 2020. Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway. Food Funct. 11(3):2427–2438.
   PubMed Web of Science ®Google Scholar
• Qi Y, Cheng X, Jing H, Yan T, Xiao F, Wu B, Bi K, Jia Y. 2019. Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model. Metab Brain Dis. 34(6):1689–1703.
   PubMed Web of Science ®Google Scholar
• Song F, Zeng K, Liao L, Yu Q, Tu P, Wang X. 2016. Schizandrin A inhibits microglia-mediated neuroninflammation through inhibiting TRAF6-NF-κB and Jak2-Stat3 signaling pathways. PLOS One. 11(2):e0149991.
   PubMed Web of Science ®Google Scholar
• Song L, Piao Z, Yao L, Zhang L, Lu Y. 2020. Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats. Exp Anim. 69(3):363–373.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu T, Wang M, Zhang F, Zhang G, Zhao J, Zhang Y, Wu E, Li X. 2019. Icariin attenuates M1 activation of microglia and Aβ plaque accumulation in the hippocampus and prefrontal cortex by up-regulating PPARγ in restraint/isolation-stressed APP/PS1 mice. Front Neurosci. 13:291.
   PubMed Web of Science ®Google Scholar
• Wei BB, Liu MY, Chen ZX, Wei MJ. 2018. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain. Acta Pharmacol Sin. 39(4):616–625.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Yu W, Tian Q, Fu X, Wang X, Gu M, Lü Y. 2017. Chitinase1 contributed to a potential protection via microglia polarization and Aβ oligomer reduction in d-galactose and aluminum-induced rat model with cognitive impairments. Neuroscience. 355:61–70.
   PubMed Web of Science ®Google Scholar
• Xu Q, Xu W, Cheng H, Yuan H, Tan X. 2019. Efficacy and mechanism of cGAMP to suppress Alzheimer's disease by elevating TREM2. Brain Behav Immun. 81:495–508.
   PubMed Web of Science ®Google Scholar
• Yao K, Zu HB. 2020. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease. Inflammopharmacology. 28(1):95–110.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jiang Q, Wang S. 2018. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. Breast Cancer. 25(2):233–242.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang Y, Zhang Y, Wei X, Wang H, Zhang M, Yang Z, Zhang C. 2019. The protective underlying mechanisms of schisandrin on SH-SY5Y cell model of Alzheimer's disease. J Toxicol Environ Health A. 82(19):1019–1026.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Qin W, Liu S, Kwong J, Zhou J, Chen J. 2014. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst. Rev. 4:CD005052.
   Google Scholar
• Zhu P, Li J, Fu X, Yu Z. 2019. Schisandra fruits for the management of drug-induced liver injury in China: a review. Phytomedicine. 59:152760.
   PubMed Web of Science ®Google Scholar